FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890512043> ?p ?o ?g. }

• W2890512043 endingPage "432" @default.
• W2890512043 startingPage "423" @default.
• W2890512043 abstract "Previous molecular subtyping for bladder carcinoma (BLCA) involved <450 samples, with diverse classifications.To identify molecular subtypes by curating a large BLCA dataset.Gene expression publicly available were combined and reanalyzed. The dataset contained 2411 unique tumors encompassing non-muscle-invasive (NMIBC) and muscle-invasive BLCA (MIBC). Subtypes were reproduced on The Cancer Genome Atlas, UROMOL, and IMvigor210.Subtypes were assigned by gene expression.Kaplan-Meier analyses were performed for subtype-clinical outcome correlations; Chi-square/Fisher exact tests were used for subtype-clinicopathological parameters associations.We identified six molecular subtypes with different overall survival (OS) and molecular features. Subtype Neural-like (median OS, 87 mo) is prevalent in MIBC and characterized by high WNT/β-catenin signaling. HER2-like (107.7 mo) is distributed evenly across NMIBC and MIBC, with higher ERBB2 amplification and signaling. Papillary-like (>135 mo), an NMIBC subtype enriched in urothelial differentiation genes, shows a high frequency of actionable FGFR3 mutations, amplifications, and FGFR3-TACC3 fusion. Luminal-like (91.7 mo), predominantly NMIBC, has higher MAPK signaling and more KRAS and KMT2C/D mutations than other subtypes. Mesenchymal-like (MES; 86.6 mo) and Squamous-cell carcinoma-like (SCC; 20.6 mo) are predominant in MIBC. MES is high in AXL signaling, whereas SCC has elevated PD1, CTLA4 signaling, and macrophage M2 infiltration. About 20% of NMIBCs show MIBC subtype traits and a lower 5-yr OS rate than Papillary-like NMIBC (81% vs 96%). The main limitations of our study are the incomplete clinical annotation, and the analyses were based on transcriptome subset due to comparisons across gene expression quantification technologies.BLCA can be stratified into six molecular subtypes. NMIBC, with a high risk of progression, displays the molecular features of MIBC.Biomarkers are urgently needed to guide patient treatment selection and avoid unnecessary toxicities in those who fail to respond. We believe molecular subtyping is a promising way to tailor disease management for those who will benefit most." @default.
• W2890512043 created "2018-09-27" @default.
• W2890512043 creator A5001000565 @default.
• W2890512043 creator A5012262880 @default.
• W2890512043 creator A5014898667 @default.
• W2890512043 creator A5038352573 @default.
• W2890512043 creator A5039283945 @default.
• W2890512043 date "2019-03-01" @default.
• W2890512043 modified "2023-10-13" @default.
• W2890512043 title "Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors" @default.
• W2890512043 cites W1741045503 @default.
• W2890512043 cites W1944353728 @default.
• W2890512043 cites W1971208896 @default.
• W2890512043 cites W1985987855 @default.
• W2890512043 cites W2033525264 @default.
• W2890512043 cites W2033775272 @default.
• W2890512043 cites W2035297454 @default.
• W2890512043 cites W2062199288 @default.
• W2890512043 cites W2067964015 @default.
• W2890512043 cites W2068523052 @default.
• W2890512043 cites W2081410358 @default.
• W2890512043 cites W2106292881 @default.
• W2890512043 cites W2107665951 @default.
• W2890512043 cites W2108068107 @default.
• W2890512043 cites W2115462905 @default.
• W2890512043 cites W2124614719 @default.
• W2890512043 cites W2130410032 @default.
• W2890512043 cites W2144864295 @default.
• W2890512043 cites W2145424370 @default.
• W2890512043 cites W2157132621 @default.
• W2890512043 cites W2163941629 @default.
• W2890512043 cites W2167198989 @default.
• W2890512043 cites W2168113705 @default.
• W2890512043 cites W2169752008 @default.
• W2890512043 cites W2193810110 @default.
• W2890512043 cites W2252644942 @default.
• W2890512043 cites W2289712604 @default.
• W2890512043 cites W2299181842 @default.
• W2890512043 cites W2426844253 @default.
• W2890512043 cites W2462649057 @default.
• W2890512043 cites W2527955139 @default.
• W2890512043 cites W2588621824 @default.
• W2890512043 cites W2600167055 @default.
• W2890512043 cites W2604535399 @default.
• W2890512043 cites W2620920447 @default.
• W2890512043 cites W2747045298 @default.
• W2890512043 cites W2755507863 @default.
• W2890512043 cites W2763670669 @default.
• W2890512043 cites W2778576237 @default.
• W2890512043 cites W2782546217 @default.
• W2890512043 cites W2783517470 @default.
• W2890512043 cites W2785803176 @default.
• W2890512043 cites W2791520553 @default.
• W2890512043 cites W2795679584 @default.
• W2890512043 cites W2917837889 @default.
• W2890512043 cites W4211053712 @default.
• W2890512043 doi "https://doi.org/10.1016/j.eururo.2018.08.027" @default.
• W2890512043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30213523" @default.
• W2890512043 hasPublicationYear "2019" @default.
• W2890512043 type Work @default.
• W2890512043 sameAs 2890512043 @default.
• W2890512043 citedByCount "182" @default.
• W2890512043 countsByYear W28905120432019 @default.
• W2890512043 countsByYear W28905120432020 @default.
• W2890512043 countsByYear W28905120432021 @default.
• W2890512043 countsByYear W28905120432022 @default.
• W2890512043 countsByYear W28905120432023 @default.
• W2890512043 crossrefType "journal-article" @default.
• W2890512043 hasAuthorship W2890512043A5001000565 @default.
• W2890512043 hasAuthorship W2890512043A5012262880 @default.
• W2890512043 hasAuthorship W2890512043A5014898667 @default.
• W2890512043 hasAuthorship W2890512043A5038352573 @default.
• W2890512043 hasAuthorship W2890512043A5039283945 @default.
• W2890512043 hasConcept C104317684 @default.
• W2890512043 hasConcept C121608353 @default.
• W2890512043 hasConcept C126322002 @default.
• W2890512043 hasConcept C137620995 @default.
• W2890512043 hasConcept C143998085 @default.
• W2890512043 hasConcept C199360897 @default.
• W2890512043 hasConcept C2780352672 @default.
• W2890512043 hasConcept C2781187634 @default.
• W2890512043 hasConcept C41008148 @default.
• W2890512043 hasConcept C502942594 @default.
• W2890512043 hasConcept C526805850 @default.
• W2890512043 hasConcept C54355233 @default.
• W2890512043 hasConcept C71924100 @default.
• W2890512043 hasConcept C83852419 @default.
• W2890512043 hasConcept C86803240 @default.
• W2890512043 hasConceptScore W2890512043C104317684 @default.
• W2890512043 hasConceptScore W2890512043C121608353 @default.
• W2890512043 hasConceptScore W2890512043C126322002 @default.
• W2890512043 hasConceptScore W2890512043C137620995 @default.
• W2890512043 hasConceptScore W2890512043C143998085 @default.
• W2890512043 hasConceptScore W2890512043C199360897 @default.
• W2890512043 hasConceptScore W2890512043C2780352672 @default.
• W2890512043 hasConceptScore W2890512043C2781187634 @default.
• W2890512043 hasConceptScore W2890512043C41008148 @default.
• W2890512043 hasConceptScore W2890512043C502942594 @default.

• next